Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/14966| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kiernan, Urban A | en_US |
| dc.contributor.author | Phillips, David A | en_US |
| dc.contributor.author | Trenchevska, Olgica | en_US |
| dc.contributor.author | Nedelkov, Dobrin | en_US |
| dc.date.accessioned | 2021-09-29T06:48:05Z | - |
| dc.date.available | 2021-09-29T06:48:05Z | - |
| dc.date.issued | 2011-03-30 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.12188/14966 | - |
| dc.description.abstract | Retinol Binding Protein 4 (RBP4) is an exciting new biomarker for the determination of insulin resistance and type 2 diabetes. It is known that circulating RBP4 resides in multiple variants which may provide enhanced clinical utility, but conventional immunoassay methods are blind to such differences. A Mass Spectrometric immunoassay (MSIA) technology that can quantitate total RBP4 as well as individual isoforms may provide an enhanced analysis for this biomarker. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Public Library of Science (PLoS) | en_US |
| dc.relation.ispartof | PloS one | en_US |
| dc.title | Quantitative mass spectrometry evaluation of human retinol binding protein 4 and related variants | en_US |
| dc.identifier.doi | 10.1371/journal.pone.0017282 | - |
| dc.identifier.url | http://dx.plos.org/10.1371/journal.pone.0017282 | - |
| dc.identifier.volume | 6 | - |
| dc.identifier.issue | 3 | - |
| item.grantfulltext | none | - |
| item.fulltext | No Fulltext | - |
| crisitem.author.dept | Faculty of Natural Sciences and Mathematics | - |
| Appears in Collections: | Faculty of Natural Sciences and Mathematics: Journal Articles | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.